Guangdong Provincial Key Laboratory for Research and Development of Natural Drug, School of Pharmacy, Guangdong Medical University, Zhanjiang City, Guangdong Province, 524023, People's Republic of China.
Marine Medical Research Institute of Zhanjiang, Zhanjiang City, Guangdong Province, 524023, People's Republic of China.
Drug Des Devel Ther. 2022 May 4;16:1311-1347. doi: 10.2147/DDDT.S357386. eCollection 2022.
Drug delivery for osteoarthritis (OA) treatment is a continuous challenge because of their poor bioavailability and rapid clearance in joints. Intra-articular (IA) drug delivery is a common strategy and its therapeutic effects depend mainly on the efficacy of the drug-delivery system used for OA therapy. Different types of IA drug-delivery systems, such as microspheres, nanoparticles, and hydrogels, have been rapidly developed over the past decade to improve their therapeutic effects. With the continuous advancement in OA mechanism research, new drugs targeting specific cell/signaling pathways in OA are rapidly evolving and effective drug delivery is critical for treating OA. In this review, recent advances in various IA drug-delivery systems for OA treatment, OA targeted strategies, and related signaling pathways in OA treatment are summarized and analyzed based on current publications.
骨关节炎(OA)治疗的药物递送是一个持续的挑战,因为它们在关节中的生物利用度差且清除速度快。关节内(IA)药物递送是一种常见的策略,其治疗效果主要取决于用于 OA 治疗的药物递送系统的功效。在过去十年中,已经迅速开发出不同类型的 IA 药物递送系统,如微球、纳米颗粒和水凝胶,以提高其治疗效果。随着 OA 机制研究的不断进展,针对 OA 中特定细胞/信号通路的新药迅速发展,有效的药物递送对于治疗 OA 至关重要。在本综述中,根据目前的出版物,总结和分析了各种用于 OA 治疗的 IA 药物递送系统、OA 靶向策略以及 OA 治疗中的相关信号通路的最新进展。